Insufficient scRNA-seq data for expression of ENPP7 at single-cell level.
Insufficient scRNA-seq data for expression of ENPP7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 602.28 | 226 / 226 | 83% | 16.42 | 337 / 406 |
| kidney | 97% | 313.96 | 86 / 89 | 44% | 2.91 | 399 / 901 |
| spleen | 92% | 20.54 | 222 / 241 | 0% | 0 | 0 / 0 |
| lung | 68% | 4.89 | 391 / 578 | 1% | 0.05 | 14 / 1155 |
| pancreas | 65% | 2.94 | 213 / 328 | 3% | 0.10 | 5 / 178 |
| peripheral blood | 55% | 9.26 | 509 / 929 | 0% | 0 | 0 / 0 |
| intestine | 48% | 60.26 | 464 / 966 | 2% | 0.09 | 10 / 527 |
| adrenal gland | 43% | 1.60 | 111 / 258 | 1% | 0.03 | 2 / 230 |
| breast | 41% | 2.17 | 187 / 459 | 0% | 0.02 | 4 / 1118 |
| stomach | 33% | 1.33 | 118 / 359 | 5% | 0.16 | 14 / 286 |
| adipose | 36% | 1.45 | 429 / 1204 | 0% | 0 | 0 / 0 |
| thymus | 32% | 1.38 | 207 / 653 | 0% | 0 | 0 / 605 |
| bladder | 29% | 1.05 | 6 / 21 | 1% | 0.03 | 6 / 504 |
| brain | 29% | 1.16 | 770 / 2642 | 0% | 0 | 0 / 705 |
| prostate | 27% | 0.88 | 67 / 245 | 0% | 0 | 0 / 502 |
| esophagus | 17% | 0.66 | 241 / 1445 | 8% | 0.32 | 14 / 183 |
| blood vessel | 23% | 0.87 | 305 / 1335 | 0% | 0 | 0 / 0 |
| uterus | 19% | 0.63 | 33 / 170 | 1% | 0.10 | 5 / 459 |
| heart | 20% | 0.75 | 170 / 861 | 0% | 0 | 0 / 0 |
| ovary | 19% | 0.54 | 35 / 180 | 0% | 0 | 0 / 430 |
| muscle | 15% | 0.50 | 118 / 803 | 0% | 0 | 0 / 0 |
| skin | 11% | 0.56 | 207 / 1809 | 0% | 0 | 0 / 472 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 0.13 | 3 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_2000304 | Biological process | positive regulation of ceramide biosynthetic process |
| GO_0008285 | Biological process | negative regulation of cell population proliferation |
| GO_0045797 | Biological process | positive regulation of intestinal cholesterol absorption |
| GO_2000755 | Biological process | positive regulation of sphingomyelin catabolic process |
| GO_0008156 | Biological process | negative regulation of DNA replication |
| GO_0055089 | Biological process | fatty acid homeostasis |
| GO_1904729 | Biological process | regulation of intestinal lipid absorption |
| GO_0044241 | Biological process | lipid digestion |
| GO_0006684 | Biological process | sphingomyelin metabolic process |
| GO_0046479 | Biological process | glycosphingolipid catabolic process |
| GO_0005902 | Cellular component | microvillus |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0004767 | Molecular function | sphingomyelin phosphodiesterase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0008081 | Molecular function | phosphoric diester hydrolase activity |
| Gene name | ENPP7 |
| Protein name | Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 (E-NPP 7) (NPP-7) (EC 3.1.4.12) (Alkaline sphingomyelin phosphodiesterase) (Intestinal alkaline sphingomyelinase) (Alk-SMase) Ectonucleotide pyrophosphatase/phosphodiesterase 7 |
| Synonyms | UNQ3077/PRO9912 |
| Description | FUNCTION: Choline-specific phosphodiesterase that hydrolyzes sphingomyelin releasing the ceramide and phosphocholine and therefore is involved in sphingomyelin digestion, ceramide formation, and fatty acid (FA) absorption in the gastrointestinal tract . Has also phospholipase C activity and can also cleave phosphocholine from palmitoyl lyso-phosphatidylcholine and platelet-activating factor (PAF) leading to its inactivation . Does not have nucleotide pyrophosphatase activity . May promote cholesterol absorption by affecting the levels of sphingomyelin derived from either diet or endogenous sources, in the intestinal lumen (By similarity). . |
| Accessions | I3L3G5 ENST00000328313.10 ENST00000576512.1 Q6UWV6 |